Successful treatment of severe plaque psoriasis with secukinumab in a patient with myasthenia gravis: Case report

The treatment of severe psoriasis is often tailored around patients needs, weighting the potential benefits and side-effects. Patients' comorbidities can often make the effective treatment challenging. In the herein report, we present our experience of a patient in whom the treatment of severe psoriasis didn't aggravate myasthenia gravis (MG) symptomatology. A 60-year-old Caucasian man was first admitted to our institution suffering from severe plaque psoriasis in 2014. His medical history included MG for which was treated with neostigmine for the past 30 years.